A Chinese group led by drugmaker Shanghai Pharmaceuticals Holding Co Ltd and private equity firm Primavera Capital has agreed to buy Australian vitamins maker Vitaco Holdings for A$313.7 million ($239 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
